Physical therapy, Observational study, Medicine, External validity, Disease-modifying antirheumatic drug, Disease activity, Cut-off,
|
Spondylitis, Severity of illness, Physical therapy, Medicine, Erythrocyte sedimentation rate, Discriminant function analysis, Cohort
|
To evaluate various validity aspects of four disease activity scores (ASDAS) for ankylosing spondylitis (AS) in comparison with the Ba
|
To develop a new index for disease activity in ankylosing spondylitis (ASDAS) that is truthful, discriminative and feasible, and inclu
|
In patients with spondyloarthritis, to determine Ankylosing Spondylitis Disease Activity Score (ASDAS) cutoffs matching the patient-ac
|
spondyloarthritis, low back pain, ankylosing spondylitis, disease activity, outcomes research, Spondylitis, Severity of illness, Rhe
|
Spondylarthropathies, Physical therapy, Medicine, International Classification of Functioning, Disability and Health, Disease, Clini
|
AbstractThe aim of this study was to compare the discriminative ability of Ankylosing Spondylitis Disease Activity Score (ASDAS) with
|
Background: We aimed to investigate the haplotypes and alleles of two variants (rs2794521 and rs3091244) in AS patients and to examine
|
AbstractThe objective of the study was to study the clinical utility of the Ankylosing Spondylitis Disease Activity Score (ASDAS) for
|
AbstractThe aim of this study was to assess discriminant validity of Ankylosing Spondylitis Disease Activity Score (ASDAS)-C-reactive
|
AbstractRecently, the Ankylosing Spondylitis Disease Activity Score (ASDAS), a new index, has been shown to be validated and highly di
|
Abstract Objectives: To investigate discrimination ability of the Assessment of Spondyloarthritis International Society (ASAS) endo
|
INTRODUCTION
The Ankylosing Spondylitis Disease Activity Score with C-reactive protein (ASDAS-CRP) and Bath Ankylosing Spondylitis Dis
|
Adult, Aged, Arthritis, Psoriatic, complications, diagnosis, drug therapy, Back Pain, etiology, Epidemiologic Methods, Female, Human
|
spondyloarthritis, low back pain, ankylosing spondylitis, disease activity, outcomes research
|
Adult, Angiogenesis Inducing Agents, blood, Antirheumatic Agents, pharmacology, therapeutic use, Biological Markers, Bone Remodeling
|
OBJECTIVE
To compare Ankylosing Spondylitis Disease Activity Score (ASDAS) ≥2.1 with BASDAI >4 as an eligibility criterion for initi
|
Adult, Antibodies, Monoclonal, therapeutic use, Antibodies, Monoclonal, Humanized, Antirheumatic Agents, Epidemiologic Methods, Fema
|
Objective. To assess the impact of achieving Assessment in SpondyloArthritis international Society 40% (ASAS40) response or an Ankylos
|
|
